Frias JP et al (2020) Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
This increased adhesion promotes greater uptake of quercetin by intestinal cells and enhances its antioxidant activity
Simply chill, open, and experience the legendary RYSE performance you've come to expect
Instead of running a marathon from the very beginning like current drugs do, our targeting downstream pathways in support cells is like starting the race halfway through, reducing the unpleasant side effects many people experience, says Doyle
That said, GLP-1, like any medication, may have side effects
But you can certainly see them, which for some users is half the point